Donna Ambrosino
Directeur/Bestuurslid bij CLOVER BIOPHARMACEUTICALS, LTD.
Vermogen: 6 925 $ op 30-04-2024
Profiel
Donna M.
Ambrosino is a professional with a doctorate degree from Dartmouth Medical School and an undergraduate degree from Harvard University.
She is currently a Non-Executive Director at Clover Biopharmaceuticals Ltd.
since 2022.
Previously, she worked as the Chief Medical Officer at Visterra, Inc. from 2012 to 2014.
She also held the position of Associate Professor at Harvard Medical School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-04-2024 | 156 992 ( 0.01% ) | 6 925 $ | 30-04-2024 |
Actieve functies van Donna Ambrosino
| Bedrijven | Functie | Begin |
|---|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Directeur/Bestuurslid | 17-06-2022 |
Eerdere bekende functies van Donna Ambrosino
| Bedrijven | Functie | Einde |
|---|---|---|
| VISTERRA INC | Hoofd Techniek/Wetenschap/O&O | 01-01-2014 |
| Harvard Medical School | Corporate Officer/Principal | - |
Opleiding van Donna Ambrosino
| Dartmouth Medical School | Doctorate Degree |
| Harvard University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Visterra, Inc.
 Visterra, Inc. Pharmaceuticals: MajorHealth Technology Visterra, Inc. Is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of antibody-based therapies for kidney diseases, and other chronic diseases. It focuses on its research technology platform, HIEROTOPE technology. The company was founded by Alan L. Crane, Kevin J. Bitterman and Ram Sasisekharan on December 20, 2007 and is headquartered in Waltham, MA. | Health Technology |
